Medicare AdvantagePrior AuthHigh impact
MA11.004p, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jul 28, 2025
We identified it
Jun 19, 2026
Summary
Policy MA11.004p establishes updated medical necessity criteria for surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH). This recent policy (effective 07/28/2025) changes how Medicare Advantage plans evaluate and authorize BPH procedures. The billing team must understand the new criteria to ensure proper prior authorization submissions and claim documentation.
Action Required
By 07/28/2025: Billing team must obtain and review the full MA11.004p policy text to identify specific medical necessity criteria, required documentation, and any prior authorization requirements for BPH surgical and minimally invasive procedures. Urology providers must update encounter documentation templates and prior authorization request forms to align with the new criteria. Before submitting claims for BPH procedures to Medicare Advantage plans, verify all medical necessity documentation is present per the updated policy. Failure to comply with new medical necessity criteria may result in claim denials. Designate a team member to monitor the IBX policy portal for the complete policy details if not yet fully published.